A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma (Q37432527)
Jump to navigation
Jump to search
scientific article published on 02 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma |
scientific article published on 02 August 2010 |
Statements
1 reference
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma (English)
1 reference
Mark Munsell
1 reference
Karen H Lu
1 reference
David M Gershenson
1 reference
Brian M Slomovitz
1 reference
Taren Johnston
1 reference
Robert L Coleman
1 reference
Russell R Broaddus
1 reference
Cheryl Walker
1 reference
Lois M Ramondetta
1 reference
Thomas W Burke
1 reference
Judith Wolf
1 reference
1 reference
1 reference
Identifiers
1 reference